โ† Back to SureMediks
๐Ÿ’Š From Biometrics to Better Outcomes ยท Pharma Partners

Turning Therapy Assets into
Intelligent Care
Ecosystems.

R2GConnect is the AI-powered engagement infrastructure pharma companies license, white-label and deploy to support therapy brands, generate real-world evidence, and deepen HCP relationships โ€” without building from scratch.

Pharma Research
๐Ÿ’Š
$637B
Annual adherence
gap (IQVIA 2023)
๐Ÿ“Š
72%
HCPs want digital
tools from pharma
50%
Non-Adherence Rate
Patients who abandon therapy (WHO)
$637B
Annual Revenue Lost
To poor adherence globally (IQVIA)
72%
HCPs Want Digital Tools
From pharma partners (Veeva 2024)
40%
Eligible Patients
Never receive indicated therapy
Three Ways Pharma Wins

One Platform. Three High-Value
Engagement Pathways.

๐Ÿฉบ

HCP Clinical Decision Support

ProView delivers real-time AI patient summaries to physicians at point of care โ€” branded to your therapy. Keeps your brand in the HCP's daily workflow without rep visits.

Real-time dashboards ยท Pharma-branded insights ยท EMR/HL7/FHIR ยท 80% faster chart review
๐Ÿ“ฑ

Automated Patient Engagement

White-label patient platform for adherence, education and remote monitoring. Enrol โ†’ Monitor โ†’ Educate โ†’ Alert โ†’ Report. Deployable in 60โ€“90 days under your brand.

Co-branded app ยท Adherence alerts ยท 95% maintenance rate ยท Multinational scalable
๐Ÿ“Š

RWE & Patient Identification

Continuous biometric data streams generate publication-grade real-world evidence. AI identifies undertreated patients within provider networks eligible for your therapy.

Longitudinal RWE ยท Open API ยท Payer negotiation support ยท Patient identification
Clinical Research Published
Why This De-Risks Your Partnership

We've Already Generated
the Evidence You Pay For

Most pharma digital partnerships are built on a promise. Ours is built on a peer-reviewed publication. The same RWE capability that produced our Springer Nature 2024 trial is deployable for your therapy brand.

391
Participants ยท Multinational
14%
Avg. Weight Loss ยท 24 wks
95%
Maintenance Rate
100%
Patient Engagement
๐Ÿ“„
Peer-Reviewed Publication
Obesity Surgery ยท Springer Nature ยท 2024
210 Altmetric ยท 12 Citations ยท IFSO & ASMBS Recognised ยท 4 Patents
Discuss a Partnership โ†’
Therapy-Agnostic Platform

Not Built for One Drug.
Built for Every Drug You Bring to It.

๐Ÿ’Š

GLP-1 & Obesity

Adherence companion for Ozempic, Wegovy & metabolic therapies. Biometric monitoring + AI lifestyle guidance.

๐Ÿฉบ

Metabolic Disease

Diabetes, NAFLD, hypertension โ€” continuous monitoring integrated with therapy protocols.

๐ŸŽ—๏ธ

Oncology Support

Oral oncolytics adherence & remote toxicity monitoring. Patient-reported outcomes automated by AI.

โš—๏ธ

Specialty Therapeutics

High-touch programmes for complex specialty regimens with AI personalisation at scale.

๐Ÿ”ฌ

Decentralised Trials

Remote recruitment, biometric data collection and AI-driven protocol adherence monitoring.

๐Ÿ›ก๏ธ

Preventive Care & RPM

CMS-reimbursed Remote Patient Monitoring programmes โ€” continuous biometric data across device types.

From Biometrics to Better Outcomes

Ready to Build the Future
of Pharma Engagement?

Let's take your therapy brand beyond the pill โ€” together.